Conferences

SCS AUA 2024: Pelvic Exenteration and Urologic Complications: A 90-Day Audit of the Practice at a Single Tertiary Level Medical Center November 2, 2024

SCS AUA 2024: Multiparametric MRI in the Evaluation of Small Renal Masses November 2, 2024

SCS AUA 2024: Financial Toxicity in Testicular Cancer Treatment, Validated Questionnaire Correlated Software Cost Modeling November 2, 2024

SCS AUA 2024: Does the Use of Continuous Bladder Irrigation After TURBT Increase the Risk of Complications? November 2, 2024

SCS AUA 2024: Should Veterans be Classified as High Risk for Prostate Cancer Screening: A Review of the Current Literature November 1, 2024

SCS AUA 2024: Can the PSMA PET SUVmax Predict High Risk Pathology and High Risk Disease? A Single Center Prospective Disease November 1, 2024

SCS AUA 2024: Elucidating the Response Rates to Additional BCG: Implications for Clinical Trial Design November 1, 2024

SCS AUA 2024: Can We Predict Locally Advanced Disease Features with PSMA PET? Correlation of Molecular Imaging TNM with Pathological TNM in Radical Prostatectomy Specimen November 1, 2024

SCS AUA 2024: Real-World Treatments Following BCG Induction in Patients with NMIBC: A Contemporary US Claims Analysis November 1, 2024

SCS AUA 2024: Urothelial Carcinoma of the Prostate and Intravesical Therapy: A Cautionary Tale November 1, 2024

SCS AUA 2024: Nephron Sparing Surgery for Localized Renal Masses November 1, 2024

SCS AUA 2024: Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis November 1, 2024

SCS AUA 2024: Efficacy of Intravesical Nadofaragene Firadenovec-VNCG for Patients with BCG-Unresponsive NMIBC: 36-Month Follow-Up from a Phase 3 Trial November 1, 2024

SCS AUA 2024: Case Discussion: Management of Localized Renal Masses in Younger Patients and Patients with Heritable Kidney Cancer Syndromes November 1, 2024

SCS AUA 2024: Adjuvant Immunotherapy in High-Risk Muscle Invasive Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Randomized Clinical Trials November 1, 2024

SCS AUA 2024: Bladder Cancer Recurrence Analysis in Veterans and Outcomes (BRAVO): White Light Versus Blue Light Cystoscopy Outcomes Among NMIBC Patients in an Equal Access Setting October 31, 2024

SCS AUA 2024: Exposures and Bladder Cancer Risk Among Military Veterans: A Systemic Review and Meta-Analysis October 31, 2024

SCS AUA 2024: Indications and Outcomes for Ablation Therapy in Renal Masses October 31, 2024

SCS AUA 2024: Indications and Outcomes for Radiation Therapy in Renal Masses October 31, 2024

SCS AUA 2024: High Risk NMIBC Treatment: The Case for Radical Cystectomy October 31, 2024

Page 1 of 589